{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:18:24Z","timestamp":1788301104828,"version":"build-2803163510"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:00:00Z","timestamp":1561507200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109124h003"],"award-info":[{"award-number":["17ek0109124h003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,13]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To evaluate diagnostic values for Epstein-Barr virus (EBV) DNA loads in different blood components of patients with EBV-positive T-cell\/natural killer cell lymphoproliferative diseases, EBV DNA loads were compared among disease categories in each blood component from 59 patients. Plasma viral loads were significantly higher in \u201cactive\u201d disease in chronic active EBV infection. EBV DNA was not detected in the plasma from 7 patients in whom EBV DNA was detected in peripheral blood mononuclear cells and whole blood. Diagnostic cutoff values for whole blood EBV DNA loads of patients with chronic active EBV infection compared with those of infectious mononucleosis was 104.2 (15 800) IU\/mL.<\/jats:p>","DOI":"10.1093\/infdis\/jiz315","type":"journal-article","created":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T22:30:43Z","timestamp":1561415443000},"page":"1307-1311","source":"Crossref","is-referenced-by-count":27,"title":["Viral DNA Loads in Various Blood Components of Patients With Epstein-Barr Virus\u2013Positive T-Cell\/Natural Killer Cell Lymphoproliferative Diseases"],"prefix":"10.1093","volume":"220","author":[{"given":"Jun-ichi","family":"Kawada","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Kamiya","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihisa","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of Virology, Nagoya University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Iwatsuki","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Osaka Women\u2019s and Children\u2019s Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Izutsu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Torii","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Hematology, Toranomon Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinori","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nagoya University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"key":"2019091313050606600_CIT0001","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"key":"2019091313050606600_CIT0002","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood.V98.2.280","article-title":"Clinical and virologic characteristics of chronic active Epstein-Barr virus infection","volume":"98","author":"Kimura","year":"2001","journal-title":"Blood"},{"key":"2019091313050606600_CIT0003","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1086\/427239","article-title":"Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection","volume":"191","author":"Kimura","year":"2005","journal-title":"J Infect Dis"},{"key":"2019091313050606600_CIT0004","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41564-018-0334-0","article-title":"Defective Epstein-Barr virus in chronic active infection and haematological malignancy","volume":"4","author":"Okuno","year":"2019","journal-title":"Nat Microbiol"},{"key":"2019091313050606600_CIT0005","first-page":"355","article-title":"Epstein-Barr virus (EBV) positive T-cell lymphoproliferative diseases of childhood","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Quintanilla-Martinez","year":"2017","edition":"Revised 4th ed."},{"key":"2019091313050606600_CIT0006","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/jmv.20553","article-title":"Evaluation of apoptosis in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis","volume":"78","author":"Kawada","year":"2006","journal-title":"J Med Virol"},{"key":"2019091313050606600_CIT0007","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"2019091313050606600_CIT0008","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fonc.2019.00062","article-title":"EBV viral loads in diagnosis, monitoring, and response assessment","volume":"9","author":"Kimura","year":"2019","journal-title":"Front Oncol"},{"key":"2019091313050606600_CIT0009","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1182\/blood-2012-09-454694","article-title":"Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial","volume":"121","author":"Kanakry","year":"2013","journal-title":"Blood"},{"key":"2019091313050606600_CIT0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1128\/JCM.37.1.132-136.1999","article-title":"Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay","volume":"37","author":"Kimura","year":"1999","journal-title":"J Clin Microbiol"},{"key":"2019091313050606600_CIT0011","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","article-title":"The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases","volume":"127","author":"Kanakry","year":"2016","journal-title":"Blood"},{"key":"2019091313050606600_CIT0012","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"2019091313050606600_CIT0013","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.biologicals.2016.04.010","article-title":"A collaborative study to establish the 1st WHO International Standard for Epstein-Barr virus for nucleic acid amplification techniques","volume":"44","author":"Fryer","year":"2016","journal-title":"Biologicals"},{"key":"2019091313050606600_CIT0014","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1086\/587671","article-title":"Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation","volume":"46","author":"Gotoh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2019091313050606600_CIT0015","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jiac.2015.11.002","article-title":"Diagnostic values for the viral load in peripheral blood mononuclear cells of patients with chronic active Epstein-Barr virus disease","volume":"22","author":"Ito","year":"2016","journal-title":"J Infect Chemother"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiz315\/28938578\/jiz315.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/220\/8\/1307\/30011073\/jiz315.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T17:35:52Z","timestamp":1610040952000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/220\/8\/1307\/5523173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":15,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,6,25]]},"published-print":{"date-parts":[[2019,9,13]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz315","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,10,15]]},"published":{"date-parts":[[2019,6,25]]}}}